NCT01530828

Brief Summary

This study is designed to evaluate a novel tool to aid in the diagnosis of intestinal perforation in infants who are at high risk. Analysis of perforation rates of all infants in the three largest participating sites shows that the majority of infants with perforation will do so prior to day of life 21. This study will target the group of infants at highest risk for IP, those with birth weight less than 1000 grams, within the time frame most likely to capture the perforation. Hypothesis: An IRT value exists that can adequately differentiate premature infants with and without intestinal perforation in the first 3 weeks of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

February 8, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 10, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

August 9, 2013

Status Verified

August 1, 2013

Enrollment Period

3.1 years

First QC Date

February 8, 2012

Last Update Submit

August 7, 2013

Conditions

Keywords

Immunoreactive TrypsinogenNectrotizing EnterocolitisPremature InfantsSerial IRT

Outcome Measures

Primary Outcomes (1)

  • To determine the onset and duration of elevation in serum IRT in infants with intestinal perforation.

    3 years

Secondary Outcomes (1)

  • Determine if factors other than intestinal perforation affect serum IRT.

    3 years

Study Arms (1)

Premature infants

Weight less than 1000 grams, age 1 - 16 days.

Eligibility Criteria

Age1 Day - 16 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Premature infants less than 1000 grams, age 1-16 days

You may qualify if:

  • Informed consent
  • Birth weight less than 1000 grams
  • Admitted to investigative site within first 16 days of life.

You may not qualify if:

  • Evidence of Intestinal perforation in utero
  • Suspected or confirmed custic fibrosis
  • Abdominal wall defect or intestinal atresia
  • Concomitant medical condition that may create an unacceptable risk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospitals & Clinics of Minnesota

Saint Paul, Minnesota, 55102, United States

RECRUITING

MeSH Terms

Conditions

Intestinal PerforationEnterocolitis, NecrotizingPremature Birth

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesEnterocolitisGastroenteritisObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicpal Investigator

Study Record Dates

First Submitted

February 8, 2012

First Posted

February 10, 2012

Study Start

August 1, 2010

Primary Completion

September 1, 2013

Study Completion

August 1, 2014

Last Updated

August 9, 2013

Record last verified: 2013-08

Locations